First Bancorp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
+618
New +$229K 0.09% 129
2026
Q1
Sell
-618
Closed -$217K 133
2025
Q4
$217K Buy
+618
New +$209K 0.12% 122
2025
Q3
Sell
-618
Closed -$240K 132
2025
Q2
$240K Hold
618
0.14% 117
2025
Q1
$269K Hold
618
0.17% 105
2024
Q4
$228K Buy
618
+25
+4% +$10.5K 0.16% 112
2024
Q3
$308K Hold
593
0.21% 97
2024
Q2
$321K Hold
593
0.24% 91
2024
Q1
$307K Hold
593
0.23% 91
2023
Q4
$280K Hold
593
0.22% 95
2023
Q3
$258K Hold
593
0.23% 91
2023
Q2
$263K Hold
593
0.22% 92
2023
Q1
$273K Hold
593
0.23% 89
2022
Q4
$304K Hold
593
0.26% 77
2022
Q3
$270K Hold
593
0.24% 84
2022
Q2
$286K Hold
593
0.27% 83
2022
Q1
$292K Hold
593
0.27% 78
2021
Q4
$275K Buy
+593
New +$249K 0.24% 84

Other funds holding ELV

First Bancorp's ELV Position: Q2 2026 in Review

First Bancorp opened a new position in Elevance Health (ELV) in Q2 2026: 618 shares worth $239K. The stake represents 0.09% of the portfolio and ranks #129 among its holdings. This is a return to the name: First Bancorp previously reported a position in ELV as recently as Q4 2025.

First Bancorp first reported a position in ELV in Q4 2021 and has held it in 17 quarters since. The position peaked at $321K in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • First Bancorp held 618 shares of Elevance Health worth $239K as of Q2 2026.
  • Elevance Health was a new First Bancorp position in Q2 2026.
  • Elevance Health made up 0.09% of First Bancorp's portfolio in Q2 2026, its #129 holding.
  • First Bancorp first reported a position in Elevance Health in Q4 2021 and has held it in 17 quarters since.
  • First Bancorp's Elevance Health position peaked at $321K in Q2 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on First Bancorp's 13F filing for Q2 2026, filed 11 Aug 2026.